2021 SCSG Liver Symposium

The Southern California Society of Gastroenterology (SCSG) is pleased to announce the hybrid 2021 Liver Symposium being held December 4-5, both online and in-person at the Montage in Laguna Beach, CA.

​

The symposium will provide a unique opportunity to receive a comprehensive update in chronic liver disease from nationally renowned faculty. The educational lectures at this symposium will focus on important advances presented at the annual American Association for the Study of Liver Disease (AASLD) Meeting and/or in recent publications. You will also have ample opportunity to interact with colleagues, our expert faculty members, and industry representatives.

For questions or inquiries, please contact the SCSG via email at scsg@pacemedcom.com.

​

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with chronic liver disease.

Statement of Need

The goal of this program is to provide important clinical and scientific data on the management of chronic liver disease.

Educational Objectives

Upon completion of this symposium, participants should be better able to:

• Describe chronic liver disease (CLD) management recommendations/guidelines for new treatments
• Optimize treatment results for patients with CLD, through utilizing new therapies
• Identify new advances presented at 2021 AASLD and assess their potential impact on clinical practice

​

Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of the Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Southern California Society of Gastroenterology (SCSG).  RMCHCS is accredited by NMMS to provide continuing medical education for physicians.

RMCHCS designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

​​​

MOC Designation

Successful completion of this CME activity enables the participant to earn up to 7.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

​

​

Sincerely,​

The Liver Symposium Co-Chair Committee

Steven-Huy Han, MD

Paul Pockros, MD

Jeffrey Kahn, MD

This activity is supported by educational grants from Gilead Sciences, Inc., Boston Scientific, Inc., Salix Pharmaceuticals, Inc., Olympus, Inc., and Takeda Pharmaceuticals U.S.A., Inc.